AKYA News

The IPO market revved back to life with nine IPOs raising $5.4 billion, joined by crypto exchange Coinbase’s direct listing. SPAC activity continued to decline, with just two raising $700 million. Pipeline activity held steady, with 10 IPOs, six SPACs, and one direct listing submitting initial filings. The first major direct listing on the Nasdaq, ...read more

Akoya Biosciences, which provides spatial biology solutions for discovery and clinical research, raised $132 million by offering 6.6 million shares at $20, the high end of the range of $18 to $20. At pricing, the company commands a fully diluted market value of $793 million. Akoya delivers spatial biology solutions focused on transforming discovery and clinical research....read more

Akoya Biosciences, which provides spatial biology solutions for discovery and clinical research, announced terms for its IPO on Monday. The Marlborough, MA-based company plans to raise $125 million by offering 6.6 million shares at a price range of $18 to $20. At the midpoint of the proposed range, Akoya Biosciences would command a fully diluted market value of $753 million. ...read more

Akoya Biosciences, which provides spatial biology solutions for discovery and clinical research, filed on Friday with the SEC to raise up to $115 million in an initial public offering. Akoya delivers spatial biology solutions focused on transforming discovery and clinical research. Through its CODEX and Phenoptics platforms, reagents, software and services, the company offers...read more